Tag:

ACH-1625

Latest Headlines

Latest Headlines

Achillion shares rocket up on promising hep C data

Shares of Achillion Pharmaceuticals rocketed up 66 percent in premarket trading as investors rallied to the news that an early-stage trial had delivered proof of concept data for its hepatitis C